cbdMD Reports Preliminary Unaudited Fourth Quarter and Fiscal 2025 Results

Core Insights - cbdMD, Inc. expects year-over-year net sales to remain in line with the prior year, with quarterly net sales projected to increase between 3% and 5% [1] - The company has reported preliminary financial results for the fourth quarter of fiscal 2025, indicating a positive trend in revenue growth compared to peers [2] Financial Performance - Net sales revenue for fiscal 2025 is expected to range between $19.1 million and $19.3 million, a slight decrease from $19.5 million in fiscal 2024 [6] - For the fourth quarter of fiscal 2025, net sales revenue is anticipated to be between $4.7 million and $4.9 million, compared to $4.6 million in the same quarter of fiscal 2024 [6] - The expected net loss for fiscal 2025 is projected to improve from $3.7 million to a range of $1.9 million to $2.1 million [6] Strategic Actions - The company has taken decisive actions to strengthen its business model and create a stable foundation for long-term growth, resulting in positive revenue growth despite industry challenges [2] - cbdMD's management emphasizes disciplined cost management and a focus on profitable growth as key drivers for continued earnings improvement in fiscal 2025 [2] Product Offerings - cbdMD offers a comprehensive line of domestically produced, THC-free CBD products, including its Herbal Oasis brand of THC seltzers and Paw CBD brand for pets [3]